Louisiana senators have approved a bill to create a psychedelic-assisted therapy pilot program, using opioid settlement dollars to fund clinical trials aimed at developing alternative treatments such as psilocybin and ibogaine.
The legislation from Sen. Patrick McMath (R) passed the Senate Health and Welfare Committee, with amendments, on Wednesday. The sponsor said he filed the measure after hearing from military veterans who “opened my eyes to this world” of ...
Missouri lawmakers have approved legislation aimed at expanding therapeutic access to and research on psychedelics such as psilocybin and ibogaine for adults and military veterans.
On Wednesday, members of the House Emerging Issues Committee passed two psychedelics proposals—combining two psilocybin- and two ibogaine-focused bills from Reps. Matthew Overcast (R) and Rep. Richard West (R)—that would take a series of steps to fund psychedelics studies, prepare for federal approval of novel therapeutics and create ...
A Colorado government advisory board is recommending that the state expand its novel regulated psychedelics market by providing access to ibogaine in addition to psilocybin and psilocin, which are currently allowed.
At a meeting of the Natural Medicine Program Advisory Board on Thursday, members discussed the future of Colorado’s psychedelics program, which launched after voters approved a legalization initiative at the ballot. In a 5-2 vote, with two abstentions, ...
Former U.S. House Speaker Newt Gingrich (R-GA) says the psychedelic ibogaine represents an “astonishing breakthrough” in the nation’s current “sick care system” that’s left people with serious mental health conditions without access to promising alternative treatment options—and he intends to use his influence to advance the issue.
Gingrich, who has a mixed record on drug policy reform, spoke with W. Brian Hubbard, executive director of Americans for Ibogaine during a podcast interview that ...
The Texas House of Representatives has given initial approval to a Senate-passed bill to create a grant program to support research into the therapeutic potential of ibogaine—aiming to encourage the federal government to approve legal access to the psychedelic.
On Monday, the legislation from Sen. Tan Parker (R) cleared the House in a 141-2 vote on second reading, with final approval in the chamber pending. It cleared the Senate last week in a ...